CED Picks First Six Companies To Present at Annual Venture Conference
Posted January 27, 2006
RESEARCH TRIANGLE PARK, NC — Six Triangle-based companies are the first to be selected to present at the next Council for Entrepreneurial Development's Venture 2006 conference.
The conference will take place on May 2-3 at Pinehurst Resort in Pinehurst.
The six companies, with descriptions provided by the CED, are:
Advanced Liquid Logic (RTP, www.liquid-logic.com): Advanced Liquid Logic is developing patented microfluidic technology for portable lab-on-a-chip systems. This technology offers the opportunity for miniaturizing and automating an enormous array of liquid-based laboratory, medical, and other analyses.
Bright View Technologies (Morrisville, www.brightviewtechnologies.com): Bright View Technologies is a leading developer of innovative, microstructure based, optical films for the global display industry. Bright View is leveraging a unique and proprietary platform technology, X-LAMPS, that enables the creation of highly engineered plastic films with superior light management characteristics.
Broadwick Corporation (Durham, www.broadwick.com): Broadwick is a provider of leading email communications software. Broadwick's flagship product, IntelliContact, allows small businesses and associations to easily create, send, and track permission-based email newsletters, promotions, announcements, and surveys. Its enterprise-level offering, IntelliCampaign, allows customers to build stronger relationships with their customers and prospects and manage one-to-many corporate email communications.
Emu Software (Cary, www.emusoftware.com): Emu Software is a Linux Server Configuration Management Software Provider. The company's NetDirector product allows businesses to easily migrate to Linux - without adding additional staff or expertise. NetDirector enables enterprises and service providers alike to benefit from the power of Linux with the simplicity of Windows.
Ercole Biotech (RTP, www.ercolebiotech.com): Ercole Biotech creates and develops drugs that direct splicing of messenger RNA. Ercole's therapeutics are designed to alter pre-mRNA splicing and can be used to up-regulate or downregulate protein expression, switch gene expression from one protein isoform to another, and restore function to defective genes.
Visitar (Raleigh, www.visitar.com): Visitar (formerly AppCentrex) provides leading, affordable hosted services for communications-enabled business applications. The company's "Solutions as a Service" model includes a robust suite of software applications that can be configured by the end user to optimally fit their unique business needs.
Companies interested in presenting can still apply. The deadline is Jan. 31.